Thiogenesis Therapeutics, Corp. (TTIPF)

CIK 1877778 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Thiogenesis Therapeutics, Corp..

Recent SEC filings

FiledFormAccession number
Jun 9, 2026D0001062993-26-003123
Aug 8, 2025D0001062993-25-013902
Dec 20, 2023D0001062993-23-022931
Nov 25, 2022D0001062993-22-022769
Aug 11, 2021D0001062993-21-007309